Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro side effects most commonly begin within the first 24 to 72 hours after your initial injection, and they tend to cluster around the gastrointestinal system: nausea, loose stools, and a feeling of fullness that arrives quickly and lingers. For most people, the pattern shifts noticeably after the first two weeks as the body adjusts. Mounjaro (tirzepatide) is a prescription-only medicine; a GPhC-registered prescriber assesses your full health picture before it is dispensed, which means side-effect management starts before your first pen arrives.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common question our prescribers field in the days after a first pen is some version of: "Is this normal?" The honest answer is usually yes, and it's worth knowing why before you inject, not after.
Tirzepatide activates both GIP and GLP-1 receptors in the gut, slowing gastric emptying so that food sits longer in your stomach. That slowing is why appetite falls. It's also why nausea is the most frequently reported early effect. According to the NHS tirzepatide medicines page, nausea, diarrhoea, vomiting, constipation, and indigestion are all common in this early window.
A misconception worth setting aside gently: many people assume that feeling sick means the medicine is working especially hard. It doesn't. The nausea reflects adaptation to slowed gastric emptying, not the extent of weight loss to come. Starting at the 2.5 mg dose (which exists purely to let your body acclimatise) keeps these early effects as mild as possible for most people.
Fatigue and headache can also appear in the first couple of days, and if you want to understand how soon after taking Mounjaro side effects tend to start, the timing can vary more than people expect. Staying well-hydrated matters more than usual in this window. Injection-site redness or mild itching is common too, and generally settles within hours.
By the end of the second week, gastrointestinal symptoms have usually softened noticeably. Your stomach has started to recalibrate to tirzepatide's presence. This is the period where most people describe the nausea shifting from something they notice every morning to something that only surfaces when they eat too quickly or choose a particularly fatty meal.
Eating habits genuinely change how this phase feels. Smaller portions, chewing slowly, and avoiding high-fat meals during this window all reduce symptom burden, practical advice that our clinical team routinely covers in aftercare. Alcohol tends to amplify nausea during this phase; so does eating right before injecting.
Constipation sometimes emerges as nausea fades, because slower gastric motility affects the whole gut. Hydration and fibre intake are the first line; any symptoms that feel severe or persist past a fortnight are worth discussing with your prescriber or GP rather than waiting them out. The Mounjaro Summary of Product Characteristics on the eMC sets out the full frequency data for each reported effect.
Burping is a side effect that surprises people, it's listed as common and tends to appear in this mid-adjustment phase. It's mundane and manageable, but worth knowing about in advance so it doesn't seem alarming.
Each time your prescriber moves you up a dose step, the early adaptation process repeats in a milder form. This is normal physiology, not a sign that the medicine has stopped suiting you. The 2.5 mg starting dose titrates upward in stages (5 mg, 7.5 mg, and so on) with a minimum of four weeks at each level. That spacing isn't arbitrary; it exists to let the side-effect curve flatten before the next increase.
People who've been on tirzepatide for several months sometimes tell us they'd forgotten what the early nausea felt like, then a dose increase reminds them, briefly. The good news is that the second adaptation is almost always shorter and gentler than the first. Most prescribers and patients find the pattern predictable enough to plan around: perhaps choosing an injection day when you have a quieter 24 hours ahead.
If side effects after a dose increase feel significantly worse than the previous round, or if new symptoms appear, contact your prescriber. For a broader overview of the full side-effect profile across the treatment course, our Mounjaro side effects guide covers the complete picture in detail. Questions about how soon you get side effects from Mounjaro come up often enough that we've addressed them separately too.
The vast majority of side effects are uncomfortable rather than dangerous, and they pass. But a few warrant urgent attention, and knowing which is which matters.
Severe, persistent stomach pain (especially if it spreads toward your back and comes with or without vomiting) should prompt a call to 111 or a visit to A&E. In January 2026 the MHRA issued a Drug Safety Update specifically flagging acute pancreatitis as a known, infrequent but serious effect of GLP-1 medicines including tirzepatide; the symptom profile above is the key warning sign. Separately, our page on pancreatitis and Mounjaro sets out the evidence on how rare this complication actually is, alongside the signs to watch for.
Seek help promptly for signs of serious dehydration following prolonged vomiting or diarrhoea (dizziness, dark urine, very little urine output), signs of an allergic reaction (swelling of the face, lips or throat, difficulty breathing, widespread rash), gallbladder symptoms (sharp pain in the upper right abdomen, jaundice), or sudden changes in vision.
Low mood or thoughts of self-harm should also be reported, tell your prescriber or GP, and contact your mental health crisis team or call 999 if it feels urgent.
Side effects of any kind (including ones that feel minor) can be reported to the MHRA via the Yellow Card scheme. This data feeds into ongoing safety monitoring of newer medicines like tirzepatide, which still carries a Black Triangle (▼) status under additional MHRA surveillance.
If you want to discuss how soon after Mounjaro side effects might apply to your own health history, speaking to our prescribers as part of a free consultation is the place to start, side-effect risk and how to manage it is a central part of every assessment we do.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.